Toward a Brighter Future in Vaccine Safety Science: A Call For Investments, Capitalizing on Scientific Opportunities and A National Vaccine Safety Board

Abstract

The article argues that U.S. vaccine confidence requires an independent National Vaccine Safety Board, expanded real-world surveillance, public-responsive research, and genomic studies to distinguish causal adverse events, identify vulnerable individuals, and improve vaccine safety and trust.